ASCVD Risk, Mortality More Accurately Predicted With Liver-Specific Biomarkers
Including liver-specific biomarkers in logistic regression models helped achieve higher predictive accuracy for ASCVD risk and mortality in MASH.
United States Park City American Heart Association Atherosclerotic Cardiovascular Disease Therapeutic Agents Nonalcoholic Steatohepatitis Liver Fibrosis
Source: endocrinologyadvisor.com